Mesoblast Limited (OTCMKTS:MEOBF – Get Free Report)’s stock price shot up 7.6% during trading on Tuesday . The stock traded as high as $0.87 and last traded at $0.87. 350 shares were traded during mid-day trading, a decline of 100% from the average session volume of 78,444 shares. The stock had previously closed at $0.81.
Mesoblast Stock Performance
The business’s 50 day moving average price is $0.68 and its two-hundred day moving average price is $0.67.
Mesoblast Company Profile
Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells.
Featured Stories
- Five stocks we like better than Mesoblast
- What is the FTSE 100 index?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is Short Interest? How to Use It
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.
